verapamil has been researched along with lewis x antigen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diddens, H; Frese, G; Gekeler, V; Handgretinger, R; Kardos, G; Kimmig, A; Neumann, M; Niethammer, D | 1 |
| Bachmann, M; Bereiter-Hahn, J; Blaheta, RA; Brude, N; Cinatl, J; Encke, A; Hailer, NP; Harder, S; Leckel, K; Markus, BH; Oppermann, E; Scholz, M; Weber, S; Wittig, B | 1 |
2 other study(ies) available for verapamil and lewis x antigen
| Article | Year |
|---|---|
Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells.
Topics: Antigens, CD7; Antigens, Differentiation; Antigens, Differentiation, T-Lymphocyte; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance; Gene Expression Regulation, Neoplastic; Histocompatibility Antigens; Humans; Immunotherapy, Adoptive; Interleukin-2; Killer Cells, Lymphokine-Activated; Leukemia; Leukocyte Common Antigens; Lewis X Antigen; Membrane Glycoproteins; Phenotype; Tumor Cells, Cultured; Verapamil | 1990 |
In vitro analysis of verapamil-induced immunosuppression: potent inhibition of T cell motility and lymphocytic transmigration through allogeneic endothelial cells.
Topics: Cell Movement; Dinoprostone; E-Selectin; Endothelium, Vascular; Humans; Immune Tolerance; Intercellular Adhesion Molecule-1; Lewis X Antigen; Lymphocyte Function-Associated Antigen-1; P-Selectin; Protein Binding; T-Lymphocytes; Vascular Cell Adhesion Molecule-1; Verapamil | 2000 |